Spin off Iproteos included in Accure Therapeutics to work on drugs for central nervous system diseases

Accure Therapeutics will develop a series of candidate drugs to treat central nervous system diseases. This will start with three programs on new medicines focused on therapeutic targets from Iproteos, a spin off by the University of Barcelona and the Institute for Research in Biomedicine (IRB Barcelona) and Binoure, a spin off by the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Spanish National Research Council (CSIC). Both Iproteos and Binoure have been integrated to Accure Therapeutics.

/Public Release. View in full here.